Researchers have developed a novel compound that could transform the way we treat Alzheimer's disease, offering not just a ...

In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...

Autopsy shows widespread amyloid and tau in patient who received contaminated biological m ...

Scientists may have sniffed out a breakthrough when detecting Alzheimer’s. The degenerative disease, which affects millions ...

Campbell: Welcome to "Beyond Diagnosis," where we talk with doctors about talking with patients. I'm your host, Glenn ...

Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

A simple nasal swab may offer an unexpected window into the earliest biological signals of Alzheimer’s disease.

The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer's Disease, or AI4AD. The new $12.6 million award to advance the project's next phase, AI4AD2, brings its ...

Brain and fitness expert Rachel Daugherty shared a tip for preventing Alzheimer's that only takes a few minutes each day: ...

Alzheimer's disease (AD) is a neurodegenerative disorder that takes away a person's memory, thinking skills, and eventually ...

Alzheimer's disease is characterized by the accumulation of two proteins in the brain: amyloid-beta and tau. Tau normally ...

A proprietary monoclonal antibody targeting an inhibitory immune checkpoint pathway had favorable safety and tolerability in ...